Preventing HIV/Aids in Drug Abusing Youth

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

111 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-06-30

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project involves two studies focusing on the engagement and treatment of adolescents diagnosed with substance use disorders. Study 1 will evaluate a promising parent-based engagement intervention, Community Reinforcement Training, designed to facilitate the entry of resistant drug-abusing adolescents in treatment. The approach will be compared with an Engagement As Usual intervention condition. Study 2 involves a controlled clinical trial evaluating the efficacy of an HIV/AIDS prevention intervention embedded in family-based drug abuse treatment for reducing HIV/AIDS risk behaviors and substance use. Adolescents who are successfully engaged in treatment through Study 1 will be randomly assigned to receive either family therapy alone or family therapy with the integrated HIV/AIDS prevention intervention. Both studies are being conducted in Portland, Oregon.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention

NCT01142882

HIV Infections Hepatitis Sexually Transmitted Infections

UNKNOWN NA

Juvenile Offender HIV Prevention and Drug Abuse Services

NCT01922297

Risk Behavior Substance Abuse Delinquency

COMPLETED NA

Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth

NCT00103532

HIV Infection

COMPLETED NA

Adherence Intervention for HIV-infected Drug Users

NCT02907697

HIV Substance Use

UNKNOWN NA

A Network & Dyad HIV Prevention Intervention for IDU's - 1

NCT00218335

HIV Hepatitis

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Family Therapy plus HIV prevention

Group Type ACTIVE_COMPARATOR

IBFT /HIV prevention

Intervention Type BEHAVIORAL

Integrated Behavioral and Family Therapy (IBGT) with HIV prevention.

2

Family Therapy only.

Group Type ACTIVE_COMPARATOR

IBFT

Intervention Type BEHAVIORAL

Integrated Behavioral and Family Therapy (IBFT).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IBFT /HIV prevention

Integrated Behavioral and Family Therapy (IBGT) with HIV prevention.

Intervention Type BEHAVIORAL

IBFT

Integrated Behavioral and Family Therapy (IBFT).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Parents have an adolescent in the ages of 15-20 years.
* Have had contact with the adolescent on at least 40% of the past 90 days.
* Have some knowledge or evidence that the adolescent would meet DSM-IV diagnostic criteria for a substance abuse disorder.
* Adolescent has explicitly refused to attend any intake or therapy sessions.
* All parents' efforts to enter adolescent into treatment have failed, despite therapist's assistance.
* Residence in Portland vicinity.
* Sufficient residential stability to permit probable contact at follow-up. (e.g. not homeless at time of intake)

Exclusion Criteria

* Evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures.
* Adolescent has received residential drug treatment longer than a 2-week period in the past 90 days.

Minimum Eligible Age

15 Years

Maximum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes